The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Madrigal wins first FDA nod for NASHThe bad — Acadia abandons plans to expand pimavanserin indications The ugly — BIO backs BIOSECURE Act, boots WuXi
Published 03/18/24
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Boehringer Ingelheim to cap out-of-pocket inhaler pricesThe bad — Amylyx ALS drug falls short in phase 3 trialThe ugly — FDA delays Eli Lilly...
Published 03/11/24